NPI 1700836962: Open Payments
NPI 1700836962. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$128 in 5 payments from 3 companies in 2025. Trend: 2023 $592 · 2024 $544 · 2025 $128
Food & beverage: $128
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| HARMONY BIOSCIENCES LLC | 1 | $35 |
| ABBVIE INC. | 1 | $29 |
Products named: AUSTEDO XR, WAKIX, QULIPTA.
